{"id":28947,"date":"2016-05-17T13:02:23","date_gmt":"2016-05-17T17:02:23","guid":{"rendered":"http:\/\/sciencebusiness.technewslit.com\/?p=28947"},"modified":"2016-05-17T13:02:23","modified_gmt":"2016-05-17T17:02:23","slug":"braeburn-to-continue-n-carolina-facility-despite-hb2","status":"publish","type":"post","link":"https:\/\/technewslit.com\/sciencebusiness\/?p=28947","title":{"rendered":"Braeburn to Continue N. Carolina Facility Despite HB2"},"content":{"rendered":"<figure id=\"attachment_28948\" aria-describedby=\"caption-attachment-28948\" style=\"width: 500px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/commons.wikimedia.org\/wiki\/File:Greetings_from_North_Carolina,_state_capitol_in_Raleigh,_state_flower_the_Goldenrod_%285756036468%29.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-28948\" src=\"http:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2016\/05\/NorthCarolinaPostcard_BostonPublicLibrary_WMC.jpg\" alt=\"North Carolina postcard\" width=\"500\" height=\"318\" srcset=\"https:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2016\/05\/NorthCarolinaPostcard_BostonPublicLibrary_WMC.jpg 500w, https:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2016\/05\/NorthCarolinaPostcard_BostonPublicLibrary_WMC-300x191.jpg 300w, https:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2016\/05\/NorthCarolinaPostcard_BostonPublicLibrary_WMC-150x95.jpg 150w, https:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2016\/05\/NorthCarolinaPostcard_BostonPublicLibrary_WMC-400x254.jpg 400w\" sizes=\"auto, (max-width: 500px) 100vw, 500px\" \/><\/a><figcaption id=\"caption-attachment-28948\" class=\"wp-caption-text\">(Boston Public Library, Wikimedia Commons)<\/figcaption><\/figure>\n<p>17 May 2016. Braeburn Pharmaceuticals, a developer of treatments for opioid addiction, will continue with its plans to build a research and manufacturing facility in North Carolina, despite its opposition to a recent state law overturning local ordinances prohibiting discrimination against the LGBT (Lesbian, Gay, Bisexual and Transgender) individuals. The company says the state&#8217;s Attorney General, who also opposes the law, advised the company that it can do more good by advocating from within rather than protesting through departure.<\/p>\n<p>Braeburn&#8217;s proposed $20 million facility on Durham County, North Carolina is expected to employ 52 workers. The company says it reviewed its plans when the governor signed <a href=\"http:\/\/www.ncleg.net\/Sessions\/2015E2\/Bills\/House\/PDF\/H2v4.pdf\">House Bill or HB2<\/a>, a law that gives the state authority to overturn city or county laws providing access to school bathrooms or locker rooms based on gender identity, rather than the student&#8217;s biological sex. The law provoked a storm of protest both inside and outside the state, with a <a href=\"http:\/\/www.publicpolicypolling.com\/pdf\/2015\/PPP_Release_NC_42516.pdf\">statewide poll<\/a> at the end of April showing more voters opposed than in favor. Durham County, where the Braeburn facility is scheduled to be built, is a community that opposes the law, including the local chamber of commerce.<\/p>\n<p>&#8220;We proudly stand with the growing list of national and local businesses who have spoken out against the injustice of HB2 and in favor of LGBT rights,&#8221; says Braeburn&#8217;s president\u00a0Behshad Sheldon in a <a href=\"https:\/\/braeburnpharmaceuticals.com\/braeburn-pharmaceuticals-announces-decision-to-continue-with-north-carolina-manufacturing-facility-plans\/\">company statement<\/a>. &#8220;We seriously considered moving our manufacturing facility to another state to send a clear message about the depth of our commitment. \u00a0Ultimately, however, we concluded that abandoning Braeburn&#8217;s job creation plans in <span class=\"xn-location\">Durham County<\/span> would unfairly penalize a community that shares Braeburn&#8217;s commitment to equality.&#8221;<\/p>\n<p>The statement says Sheldon met with the state&#8217;s governor Pat McCrory who supports HB2 and Attorney General <span class=\"xn-person\">Roy Cooper<\/span>, who shares the company&#8217;s view that HB2 is unjust and needs to be overturned. Cooper&#8217;s advice prevailed that the company could have more influence on the subject if it stayed in North Carolina.<\/p>\n<p>Sheldon says the company plans to use its influence to overturn the law, saying the company &#8220;will advocate for progressive public policy, do our part to help overturn HB2, and support those who share our commitments to diversity and non-discrimination.&#8221; Sheldon adds that &#8220;Battling stigma is central to our mission as we develop medicines for people with opioid addiction, we cannot and will not support stigmatization of any member of our society.&#8221;<\/p>\n<p>Read more:<\/p>\n<ul>\n<li><a href=\"http:\/\/sciencebusiness.technewslit.com\/?p=28855\">Drug Pricing Reform Even Big Pharma Might Like<\/a><\/li>\n<li><a href=\"http:\/\/sciencebusiness.technewslit.com\/?p=28713\">Pharmacy Interventions Shown to Boost Meds Adherence<\/a><\/li>\n<li><a href=\"http:\/\/sciencebusiness.technewslit.com\/?p=28509\">Harnessing Big Data for Precision Medicine<\/a><\/li>\n<li><a href=\"http:\/\/sciencebusiness.technewslit.com\/?p=28499\">What it Takes to Innovate in the Old Economy<\/a><\/li>\n<li><a href=\"http:\/\/sciencebusiness.technewslit.com\/?p=28202\">More PhDs Heading to Industry, Improve Earnings<\/a><\/li>\n<\/ul>\n<p style=\"text-align: center;\">*\u00a0\u00a0\u00a0\u00a0 *\u00a0\u00a0\u00a0\u00a0 *<\/p>\n","protected":false},"excerpt":{"rendered":"<p>17 May 2016. Braeburn Pharmaceuticals, a developer of treatments for opioid addiction, will continue with its plans to build a research and manufacturing facility in North Carolina, despite its opposition to a recent state law overturning local ordinances prohibiting discrimination against the LGBT (Lesbian, Gay, Bisexual and Transgender) individuals. The company says the state&#8217;s Attorney [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10,6],"tags":[53,20,27],"class_list":["post-28947","post","type-post","status-publish","format-standard","hentry","category-business","category-hiringlayoffs","tag-economics","tag-manufacturing","tag-pharmaceuticals"],"_links":{"self":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/28947","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=28947"}],"version-history":[{"count":2,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/28947\/revisions"}],"predecessor-version":[{"id":28950,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/28947\/revisions\/28950"}],"wp:attachment":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=28947"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=28947"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=28947"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}